Advanced search
Publication Cover
Leukemia & Lymphoma Volume 58, 2017 - Issue 1
Submit an article Journal homepage
356
Views
5
CrossRef citations to date
0
Altmetric
Letters to the Editor

Panobinostat consolidation in patients with Hodgkin lymphoma at risk for relapse after high dose chemotherapy and autologous stem cell transplant: final results after early trial discontinuation

Bastian von TresckowDepartment of Internal Medicine I, German Hodgkin Study Group (GHSG), University Hospital of Cologne, Kerpener Str. 62, Cologne, Germany; Correspondence[email protected]
,
Franck MorschhauserHematology Department, CHRU Lille Hopital Claude Huriez, Lille, France;
,
Jeffrey SzerBone Marrow Transplant Unit, Royal Melbourne Hospital, Parkville, VIC, Australia;
,
Dennis A. EichenauerDepartment of Internal Medicine I, German Hodgkin Study Group (GHSG), University Hospital of Cologne, Kerpener Str. 62, Cologne, Germany;
,
Jeremy S. AbramsonMassachusetts General Hospital, Yawkey Center, Suite 9A, Boston, MA, USA;
,
Anna SuredaHematology Department, Hospital De La Santa Creu I Sant Pau, Mas Casanovas, Barcelona, Spain; ;Hematology Department, Institut Català D’Oncologia – L’Hospitalet, Gran via, Barcelona, Spain
&
Andreas EngertDepartment of Internal Medicine I, German Hodgkin Study Group (GHSG), University Hospital of Cologne, Kerpener Str. 62, Cologne, Germany;
show all
Pages 222-225 | Received 08 Mar 2016, Accepted 17 Apr 2016, Published online: 17 May 2016

Citations (5)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Dennis A. Eichenauer & Andreas Engert. (2017) The evolving role of targeted drugs in the treatment of Hodgkin lymphoma. Expert Review of Hematology 10:9, pages 775-782.
Read now

Articles from other publishers (4)

Natalia S. Tsaplina, Timur T. Valiev, Galina D. Petrova, Kirill I. Kirgizov & Svetlana R. Varfolomeeva. (2022) Modern approaches in relapsed and refractory Hodgkin lymphoma treatment: literature review and own experience. Journal of Modern Oncology 24:3, pages 319-324.
Crossref
Anna Sureda, Marc André, Peter Borchmann, Maria G. da Silva, Christian Gisselbrecht, Theodoros P. Vassilakopoulos, Pier Luigi Zinzani & Jan Walewski. (2020) Improving outcomes after autologous transplantation in relapsed/refractory Hodgkin lymphoma: a European expert perspective. BMC Cancer 20:1.
Crossref
Theodoros P. Vassilakopoulos, John V. Asimakopoulos, Kostas Konstantopoulos & Maria K. Angelopoulou. (2020) Optimizing outcomes in relapsed/refractory Hodgkin lymphoma: a review of current and forthcoming therapeutic strategies. Therapeutic Advances in Hematology 11, pages 204062072090291.
Crossref
Theodoros P Vassilakopoulos & Boris Böll. (2019) Treatment of Hodgkin Lymphoma – New and Developing Therapies and Their Potential Role in Standard of Care. European Oncology & Haematology 15:1, pages 53.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.